Astrocyte Pharmaceuticals
company
About
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
- 1 - 10
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Clinical Trials,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$6M
Astrocyte Pharmaceuticals has raised a total of
$6M
in funding over 2 rounds. Their latest funding was raised on
May 3, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 3, 2021 | Series A | $6M | 2 | — | — | Detail |
| Sep 21, 2015 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Astrocyte Pharmaceuticals has made 1 investments. Their most recent investment was on
Nov 6, 2019, when Digits raised $10.50M.
Investors
Number of Lead Investors
Number of Investors
1
3
Astrocyte Pharmaceuticals is funded by 3 investors.
National Institutes of Health
and DREAMERS Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
DREAMERS Ventures
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
